Plus Therapeutics Stock Price History

PSTV Stock  USD 0.56  0.03  5.08%   
If you're considering investing in Plus Stock, it is important to understand the factors that can impact its price. As of today, the current price of Plus Therapeutics stands at 0.56, as last reported on the 19th of March, with the highest price reaching 0.61 and the lowest price hitting 0.53 during the day. Plus Therapeutics is out of control given 3 months investment horizon. Plus Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0631, which implies the firm had a 0.0631 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 2.65% are justified by taking the suggested risk. Use Plus Therapeutics Semi Deviation of 11.8, risk adjusted performance of 0.0654, and Coefficient Of Variation of 1583.59 to evaluate company specific risk that cannot be diversified away.
  
Plus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0631

Best PortfolioBest Equity
Good ReturnsPSTV
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 42.0
  actual daily
96
96% of assets are less volatile

Expected Return

 2.65
  actual daily
52
52% of assets have lower returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average Plus Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Plus Therapeutics by adding it to a well-diversified portfolio.

Plus Therapeutics Stock Price History Chart

There are several ways to analyze Plus Stock price data. The simplest method is using a basic Plus candlestick price chart, which shows Plus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 7, 20251.57
Lowest PriceMarch 4, 20250.3

Plus Therapeutics March 19, 2025 Stock Price Synopsis

Various analyses of Plus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Plus Stock. It can be used to describe the percentage change in the price of Plus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Plus Stock.
Plus Therapeutics Price Action Indicator(0.02)
Plus Therapeutics Price Daily Balance Of Power(0.37)
Plus Therapeutics Price Rate Of Daily Change 0.95 

Plus Therapeutics March 19, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Plus Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Plus Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Plus Stock and then apply it to test your longer-term investment strategies against Plus.

Plus Stock Price History Data

The price series of Plus Therapeutics for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 1.27 with a coefficient of variation of 23.7. The price distribution for the period has arithmetic mean of 1.09. The median price for the last 90 days is 1.2. The company completed stock split (1:15) on 1st of May 2023. Plus Therapeutics had dividends distributed to its stock-holders on 2019-08-06.
OpenHighLowCloseVolume
03/19/2025
 0.56  0.61  0.53  0.56 
03/18/2025 0.56  0.61  0.53  0.56  3,352,907 
03/17/2025 0.70  0.70  0.56  0.59  2,231,046 
03/14/2025 0.70  0.72  0.60  0.68  2,428,411 
03/13/2025 1.10  1.10  0.75  0.75  3,511,085 
03/12/2025 1.41  1.47  1.16  1.21  2,917,453 
03/11/2025 1.28  1.89  1.28  1.43  23,403,919 
03/10/2025 1.42  1.66  1.25  1.27  5,270,535 
03/07/2025 2.02  2.31  1.27  1.57  102,615,083 
03/06/2025 0.57  1.54  0.47  1.44  359,585,000 
03/05/2025 0.33  0.37  0.31  0.35  1,069,477 
03/04/2025 0.65  0.69  0.24  0.30  4,779,600 
03/03/2025 0.70  0.72  0.63  0.66  282,042 
02/28/2025 0.71  0.85  0.68  0.73  1,129,284 
02/27/2025 0.75  0.75  0.65  0.68  317,900 
02/26/2025 1.00  1.00  0.74  0.76  381,999 
02/25/2025 1.19  1.19  1.08  1.08  47,052 
02/24/2025 1.15  1.19  1.10  1.14  72,524 
02/21/2025 1.20  1.20  1.09  1.20  68,918 
02/20/2025 1.17  1.30  1.17  1.20  163,199 
02/19/2025 1.17  1.20  1.17  1.20  9,629 
02/18/2025 1.19  1.20  1.17  1.18  42,131 
02/14/2025 1.21  1.25  1.16  1.24  39,299 
02/13/2025 1.12  1.26  1.12  1.20  53,441 
02/12/2025 1.26  1.26  1.12  1.12  26,147 
02/11/2025 1.28  1.33  1.20  1.23  29,000 
02/10/2025 1.22  1.24  1.22  1.22  5,433 
02/07/2025 1.25  1.28  1.22  1.24  16,059 
02/06/2025 1.29  1.32  1.22  1.28  18,598 
02/05/2025 1.25  1.30  1.24  1.28  30,046 
02/04/2025 1.23  1.30  1.21  1.25  40,900 
02/03/2025 1.21  1.25  1.18  1.24  29,800 
01/31/2025 1.22  1.26  1.20  1.24  28,600 
01/30/2025 1.21  1.26  1.18  1.20  8,300 
01/29/2025 1.20  1.22  1.18  1.20  5,700 
01/28/2025 1.21  1.25  1.18  1.19  13,300 
01/27/2025 1.21  1.26  1.21  1.23  20,400 
01/24/2025 1.21  1.23  1.21  1.23  15,500 
01/23/2025 1.20  1.22  1.19  1.21  6,412 
01/22/2025 1.23  1.25  1.22  1.22  7,406 
01/21/2025 1.21  1.24  1.21  1.24  10,538 
01/17/2025 1.21  1.21  1.16  1.17  8,784 
01/16/2025 1.20  1.22  1.19  1.19  12,562 
01/15/2025 1.18  1.24  1.18  1.20  18,770 
01/14/2025 1.15  1.20  1.15  1.17  16,129 
01/13/2025 1.14  1.24  1.12  1.14  18,587 
01/10/2025 1.20  1.22  1.14  1.16  16,356 
01/08/2025 1.32  1.35  1.15  1.20  75,586 
01/07/2025 1.30  1.30  1.23  1.24  36,089 
01/06/2025 1.25  1.30  1.21  1.26  72,207 
01/03/2025 1.20  1.24  1.18  1.23  44,068 
01/02/2025 1.14  1.19  1.14  1.18  29,436 
12/31/2024 1.19  1.23  1.10  1.15  40,123 
12/30/2024 1.18  1.18  1.09  1.15  43,799 
12/27/2024 1.11  1.17  1.09  1.16  38,534 
12/26/2024 1.07  1.10  1.04  1.08  28,927 
12/24/2024 1.07  1.11  1.07  1.08  7,049 
12/23/2024 1.14  1.14  1.03  1.07  40,975 
12/20/2024 1.01  1.11  0.97  1.09  49,387 
12/19/2024 1.01  1.10  0.93  0.99  84,117 
12/18/2024 1.07  1.10  0.98  1.00  79,404 

About Plus Therapeutics Stock history

Plus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Plus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Plus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Plus Therapeutics stock prices may prove useful in developing a viable investing in Plus Therapeutics
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas. Plus Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.

Plus Therapeutics Stock Technical Analysis

Plus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Plus Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Plus Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Plus Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Plus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Plus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Plus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Plus Stock Analysis

When running Plus Therapeutics' price analysis, check to measure Plus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plus Therapeutics is operating at the current time. Most of Plus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Plus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plus Therapeutics' price. Additionally, you may evaluate how the addition of Plus Therapeutics to your portfolios can decrease your overall portfolio volatility.